![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 14/705 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/30 | (2006.01) | ||
A61K 39/00 | (2006.01) |
(11) | Number of the document | 3305813 |
(13) | Kind of document | T |
(96) | European patent application number | 17189247.4 |
Date of filing the European patent application | 2010-11-11 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2020-01-15 |
(46) | Date of publication of the claims translation | 2020-05-11 |
(30) | Number | Date | Country code |
09014136 | 2009-11-11 | EP | |
260202 P | 2009-11-11 | US | |
10006956 | 2010-07-06 | EP | |
361618 P | 2010-07-06 | US |
(72) |
SAHIN, Ugur, DE
TÜRECI, Özlem, DE
KOSLOWSKI, Michael, DE
WALTER, Korden, DE
WÖLL, Stefan, DE
KREUZBERG, Maria, DE
HUBNER, Bernd, DE
ERDELJAN, Michael, DE
|
(73) |
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige Gmb,
Freiligrathstrasse 12, 55131 Mainz,
DE
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho 2-Chome, Chuo-ku Tokyo 103-8411, JP |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Antikūnai, specifiški claudin 6 (CLDN6) |
ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6) |
Payment date | Validity (years) | Amount | |
2024-10-21 | 15 | 289.00 EUR |
2025-11-11 |